Literature DB >> 1523294

Thyroid nodules associated with Hashimoto thyroiditis: assessment with US.

S Takashima1, F Matsuzuka, T Nagareda, N Tomiyama, T Kozuka.   

Abstract

Sonographic findings in 109 thyroid nodules in 104 patients with Hashimoto thyroiditis were retrospectively analyzed. Sixty patients underwent ultrasound (US)--guided fine-needle aspiration (FNA) biopsy (65 nodules, 24 palpable, 27 surgically confirmed), 14 of whom also underwent palpation-guided FNA (14 nodules, all palpable, all surgically confirmed). Forty-four patients (44 nodules, 25 palpable) underwent diagnostic US followed up with surgery. US-guided FNA helped differentiate between benign (n = 11) and malignant (n = 16) diseases (sensitivity, 100%). Two papillary carcinomas were falsely diagnosed as Hashimoto thyroiditis with palpation-guided FNA. Eight malignancies were not palpable, and correct diagnosis was obtained with US-guided FNA. Hyperechoic nodules were usually benign, and isoechoic nodules had a low frequency (13%) of malignancy. Most carcinomas were found in hypoechoic masses, and almost all lymphomas were found in markedly hypoechoic masses. Lymphoma was indistinguishable from pseudotumor in Hashimoto thyroiditis or adenomatous hyperplasia at US. US-guided FNA is helpful in making the histologic diagnosis in thyroid nodules associated with Hashimoto thyroiditis. US-guided FNA is clinically beneficial because it can help select patients who need surgery, avoiding unnecessary surgery for patients with nonneoplastic disorders.

Entities:  

Mesh:

Year:  1992        PMID: 1523294     DOI: 10.1148/radiology.185.1.1523294

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Diagnostic value of strain ratio measurement in differential diagnosis of thyroid nodules coexisted with Hashimoto thyroiditis.

Authors:  Jianhong Wang; Ping Li; Lingling Sun; Yongmei Sun; Shibao Fang; Xuejun Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Hypothyroid Hashimoto's thyroiditis with scintigraphic and echo-color Doppler features mimicking autonomous adenoma.

Authors:  F Boi; M Piga; M Loy; S Mariotti
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

3.  A comparison of lymphocytic thyroiditis with papillary thyroid carcinoma showing suspicious ultrasonographic findings in a background of heterogeneous parenchyma.

Authors:  Sang Yu Nam; Jung Hee Shin; Eun Young Ko; Soo Yeon Hahn
Journal:  Ultrasonography       Date:  2014-09-11

4.  Contrast-Enhanced Ultrasound in the Differential Diagnosis of Primary Thyroid Lymphoma and Nodular Hashimoto's Thyroiditis in a Background of Heterogeneous Parenchyma.

Authors:  Lulu Yang; Haina Zhao; Yushuang He; Xianglan Zhu; Can Yue; Yan Luo; Buyun Ma
Journal:  Front Oncol       Date:  2021-01-07       Impact factor: 6.244

5.  Using Deep Neural Network to Diagnose Thyroid Nodules on Ultrasound in Patients With Hashimoto's Thyroiditis.

Authors:  Yiqing Hou; Chao Chen; Lu Zhang; Wei Zhou; Qinyang Lu; Xiaohong Jia; Jingwen Zhang; Cen Guo; Yuxiang Qin; Lifeng Zhu; Ming Zuo; Jing Xiao; Lingyun Huang; Weiwei Zhan
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

6.  Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseases.

Authors:  Priscila Carneiro Moreira Lima; Arnaldo Moura Neto; Marcos Antonio Tambascia; Denise Engelbrecht Zantut Wittmann
Journal:  ISRN Endocrinol       Date:  2013-05-25

7.  Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.

Authors:  Sena Hwang; Dong Yeob Shin; Eun Kyung Kim; Woo Ick Yang; Jung Woo Byun; Su Jin Lee; Gyuri Kim; Soo Jung Im; Eun Jig Lee
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

8.  Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule?

Authors:  Mina Park; So Hee Park; Eun-Kyung Kim; Jung Hyun Yoon; Hee Jung Moon; Hye Sun Lee; Jin Young Kwak
Journal:  BMC Cancer       Date:  2013-11-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.